Key facts
- GI Windows’s last known valuation is $130.0M.
- It has raised $82.5M; the latest was Later Stage VC ($37.0M) in Oct 2024.
- Notable investors include Johnson & Johnson JJDC, Sonder Capital Management, Frederic Moll, GT Healthcare Capital Partners, JC Investco — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for GI Windows
- ·The full record, as it builds
Funding rounds
No funding rounds for GI Windows are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About GI Windows
Developer of anastomotic technology designed to help in tissue fusion. The company's technology offers less invasive surgery compared to traditional staplers and offers an intervention to help in curing obesity and type two diabetes, enabling healthcare providers to treat metabolic disorders on an outpatient basis and with no surgical incisions.
- Sector
- Healthcare
- HQ
- Westwood, MA, United States
- Founded
- 2012
- Employees
- 28
- Website
- giwindows.com/
- Ownership
- Privately Held (backing)
GI Windows doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GI Windows shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GI Windows in its N-PORT filings yet. We sweep new filings monthly.